T. Graves

619 total citations
9 papers, 478 citations indexed

About

T. Graves is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, T. Graves has authored 9 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in T. Graves's work include Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (2 papers) and Intraperitoneal and Appendiceal Malignancies (2 papers). T. Graves is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (2 papers) and Intraperitoneal and Appendiceal Malignancies (2 papers). T. Graves collaborates with scholars based in United States, United Kingdom and Switzerland. T. Graves's co-authors include W.J. Cunliffe, Richard E. Mullins, Paul H. Sugarbaker, P. Schlag, E. A. de Bruijn, J. Belliveau, William E. Hull, Lisa F. Clark, Andrew W. Meyers and Don S. Dizon and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Consulting and Clinical Psychology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

T. Graves

9 papers receiving 446 citations

Peers

T. Graves
Jessica A. Naiditch United States
Matthew Trokel United States
Younes N. Bakri Saudi Arabia
Peter Gillen Ireland
Adam Ostrzenski United States
C. Emi Bretschneider United States
T. Graves
Citations per year, relative to T. Graves T. Graves (= 1×) peers Stefano Magnone

Countries citing papers authored by T. Graves

Since Specialization
Citations

This map shows the geographic impact of T. Graves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Graves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Graves more than expected).

Fields of papers citing papers by T. Graves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Graves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Graves. The network helps show where T. Graves may publish in the future.

Co-authorship network of co-authors of T. Graves

This figure shows the co-authorship network connecting the top 25 collaborators of T. Graves. A scholar is included among the top collaborators of T. Graves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Graves. T. Graves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Wang, Yihong, Kamaljeet Singh, Don S. Dizon, et al.. (2021). Immunohistochemical HER2 score correlates with response to neoadjuvant chemotherapy in HER2-positive primary breast cancer. Breast Cancer Research and Treatment. 186(3). 667–676. 8 indexed citations
2.
Strenger, Rochelle, Robert D. Legare, Mary Anne Fenton, et al.. (2021). Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study. Breast Cancer Research and Treatment. 189(1). 93–101. 2 indexed citations
3.
Hepel, Jaroslaw T., K.L. Leonard, Jessica R. Hiatt, et al.. (2014). Non-Invasive Image-Guided Breast Brachytherapy (NIBB) to Deliver Accelerated Partial Breast Irradiation (APBI): Analysis of Acute Toxicity and Early Outcomes. International Journal of Radiation Oncology*Biology*Physics. 90(1). S136–S136. 5 indexed citations
4.
Graves, T., et al.. (2010). Effectiveness of a group opt-in session on uptake and graduation rates for pulmonary rehabilitation. Chronic Respiratory Disease. 7(3). 159–164. 19 indexed citations
5.
Fenton, Mary Anne, Don S. Dizon, Jennifer Gass, et al.. (2005). Neoadjuvant q4week carboplatin and weekly paclitaxel ± trastuzumab in resectable and locally advanced breast cancer: A Brown University Oncology Group (BrUOG) study. Journal of Clinical Oncology. 23(16_suppl). 759–759. 3 indexed citations
6.
Lowther, D, Thomas A. DiPetrillo, Blake Cady, et al.. (2001). A Phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. International Journal of Radiation Oncology*Biology*Physics. 51(3). 5–5. 6 indexed citations
7.
Sugarbaker, Paul H., W.J. Cunliffe, J. Belliveau, et al.. (1991). Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. PubMed. 16(4 Suppl 6). 272–275. 186 indexed citations
8.
Sugarbaker, Paul H., T. Graves, W.J. Cunliffe, et al.. (1990). Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies.. PubMed. 50(18). 5790–4. 195 indexed citations
9.
Graves, T., Andrew W. Meyers, & Lisa F. Clark. (1988). An evaluation of parental problem-solving training in the behavioral treatment of childhood obesity.. Journal of Consulting and Clinical Psychology. 56(2). 246–250. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026